Literature DB >> 3819479

Isolation of antigenic components from the Lyme disease spirochete: their role in early diagnosis.

J L Coleman, J L Benach.   

Abstract

Patients with early Lyme disease produce IgM antibodies to a 41,000-dalton polypeptide of Borrelia burgdorferi. With advancing disease, IgG antibodies recognize a larger number of spirochetal polypeptides. Sodium dodecyl sulfate treatment of spirochetes at a concentration of 0.03% resulted in an outer envelope (OE) fraction in the supernatant and a protoplasmic cylinder (PC) flagellar fraction in the pellet. Shearing of the PC pellet followed by ultrafiltration and dialysis resulted in a flagellin-enriched fraction. From the OE and flagellin-rich fractions, individual polypeptides with Mr of 66,000, 41,000, and 31,000/34,000 daltons were eluted in microgram quantities after electrophoresis. The flagellin-enriched fraction as well as the eluted polypeptides were used as antigens in the ELISA. The flagellin-enriched fraction was superior to the standard ELISA antigen. The 41-kilodalton (kDa) flagellin antigen was not useful. Antigens of 66 kDa and 31/34 kDa were confirmed to be part of the late antibody response.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3819479     DOI: 10.1093/infdis/155.4.756

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  79 in total

1.  Laboratory confirmation of Lyme disease.

Authors:  T G Schwan; W J Simpson; P A Rosa
Journal:  Can J Infect Dis       Date:  1991

2.  Borrelia burgdorferi HtrA: evidence for twofold proteolysis of outer membrane protein p66.

Authors:  James L Coleman; Alvaro Toledo; Jorge L Benach
Journal:  Mol Microbiol       Date:  2015-10-20       Impact factor: 3.501

3.  Hypercholesterolemia and ApoE deficiency result in severe infection with Lyme disease and relapsing-fever Borrelia.

Authors:  Alvaro Toledo; Javier D Monzón; James L Coleman; Juan C Garcia-Monco; Jorge L Benach
Journal:  Proc Natl Acad Sci U S A       Date:  2015-04-13       Impact factor: 11.205

4.  Further characterization of a potent immunogen and the chromosomal gene encoding it in the Lyme disease agent, Borrelia burgdorferi.

Authors:  G C Perng; R B LeFebvre; R C Johnson
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

5.  Mapping antibody-binding domains of the major outer surface membrane protein (OspA) of Borrelia burgdorferi.

Authors:  W H Schubach; S Mudri; R J Dattwyler; B J Luft
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

6.  Lyme borreliosis: host responses to Borrelia burgdorferi.

Authors:  A Szczepanski; J L Benach
Journal:  Microbiol Rev       Date:  1991-03

7.  Ovalbumin blocking improves sensitivity and specificity of immunoglobulin M immunoblotting for serodiagnosis of patients with erythema migrans.

Authors:  R Lange; H Bocklage; T Schneider; H W Kölmel; J Heesemann; H Karch
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

8.  A 55-kilodalton antigen encoded by a gene on a Borrelia burgdorferi 49-kilobase plasmid is recognized by antibodies in sera from patients with Lyme disease.

Authors:  S Feng; S Das; T Lam; R A Flavell; E Fikrig
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

9.  Serologic analyses of cottontail rabbits for antibodies to Borrelia burgdorferi.

Authors:  L A Magnarelli; J F Anderson; J B McAninch
Journal:  J Clin Microbiol       Date:  1990-05       Impact factor: 5.948

10.  The 39-kilodalton protein of Borrelia burgdorferi: a target for bactericidal human monoclonal antibodies.

Authors:  M Scriba; J S Ebrahim; T Schlott; H Eiffert
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.